Rankings
▼
Calendar
ZYME Q4 2024 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31M
+83.3% YoY
Gross Profit
$31M
100.0% margin
Operating Income
-$22M
-71.6% margin
Net Income
-$24M
-75.8% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+93.9%
Cash Flow
Operating Cash Flow
-$42M
Free Cash Flow
-$42M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$463M
Total Liabilities
$124M
Stockholders' Equity
$339M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$17M
+83.3%
Gross Profit
$31M
$17M
+83.3%
Operating Income
-$22M
-$23M
+5.1%
Net Income
-$24M
-$14M
-62.3%
Revenue Segments
Upfront Fee
$18M
100%
← FY 2024
All Quarters
Q1 2025 →